Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
[
Title
]
Type
Year
Filters:
Author
is
Sockel, Katja
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
R
Stelljes M
,
Middeke JMoritz
,
Bug G
,
Wagner-Drouet E-M
,
Müller LP
,
Schmid C
,
Krause SW
,
Bethge W
,
Jost E
,
Platzbecker U
, et al.
Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial.
Lancet Haematol. 2024.
PubMed
Google Scholar
O
Ortí G
,
Gras L
,
Zinger N
,
Finazzi MChiara
,
Sockel K
,
Robin M
,
Forcade E
,
Avenoso D
,
Kröger N
,
Finke J
, et al.
Outcomes after Allogeneic Hematopoietic Cell Transplant in patients diagnosed with Blast Phase of Myeloproliferative Neoplasms: a retrospective study from the Chronic Malignancies Working Party of the EBMT.
Am J Hematol. 2023.
PubMed
Google Scholar
M
von Dalowski F
,
Kramer M
,
Wermke M
,
Wehner R
,
Röllig C
,
Alakel N
,
Stölzel F
,
Parmentier S
,
Sockel K
,
Krech M
, et al.
Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory GvHD: Clinical Responses and Long-Term Outcome.
Stem Cells. 2015.
PubMed
Google Scholar
I
Polverelli N
,
Bonneville EF
,
de Wreede LC
,
Koster L
,
Kröger NMartin
,
Schroeder T
,
de Latour RPeffault
,
Passweg J
,
Sockel K
,
Broers AEC
, et al.
Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of EBMT.
Am J Hematol. 2024.
PubMed
Google Scholar
Tentori CA
,
Zhao LP
,
Tinterri B
,
Strange KE
,
Zoldan K
,
Dimopoulos K
,
Feng X
,
Riva E
,
Lim B
,
Simoni Y
, et al.
Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium.
Hemasphere. 2024;8(5):e64.
PubMed
Google Scholar
A
Schneider M
,
Rolfs C
,
Trumpp M
,
Winter S
,
Fischer L
,
Richter M
,
Menger V
,
Nenoff K
,
Grieb N
,
Metzeler KH
, et al.
Activation of distinct inflammatory pathways in subgroups of LR-MDS.
Leukemia. 2023.
PubMed
Google Scholar